靶向PF06463922原料藥 廠家價(jià)格（僅供科研）

PF06463922

CAS NO. 1454846-35-5
英文品名 PF-06463922
中文品名 PF-06463922
分子式 C21H19FN6O2
分子量 406.15
規(guī)格/純度 98%
供應(yīng)能力 can supply g scale
別名 PF 06463922;PF06463922
產(chǎn)品簡(jiǎn)述 PF-06463922 is a novel, orally available, CNS-penetrant, ATP-competitive inhibitor of ALK/ROS1 with Ki of <0.02 nM, <0.07 nM, and 0.7 nM for ROS1, ALK (WT), and ALK (L1196M), respectively.
詳細(xì)說(shuō)明 PF-06463922 demonstrates significant cell activity against ALK and a large set of ALK clinical mutations with IC50 ranging from 0.2 nM-77 nM. PF-06463922 exhibited subnanomolar cellular potency against oncogenic ROS1 fusions and inhibited the crizotinib-refractory ROS1(G2032R) mutation and the ROS1(G2026M) gatekeeper mutation. Compared with crizotinib and the second-generation ALK/ROS1 inhibitors ceritinib and alectinib, PF-06463922 showed significantly improved inhibitory activity against ROS1 kinase. in vivo: PF-06463922 showed marked antitumor activity in tumor models expressing FIG-ROS1, CD74-ROS1, and the CD74-ROS1(G2032R) mutation. Furthermore, PF-06463922 demonstrated antitumor activity in a genetically engineered mouse model of FIG-ROS1 glioblastoma.

    高質(zhì)量現(xiàn)貨，到貨速度快，可以滿足您從科研到商業(yè)生產(chǎn)不同發(fā)展階段的需求，公司始終秉承價(jià)格存之本的宗旨，以過(guò)硬的質(zhì)量和優(yōu)良的
價(jià)格體系維護(hù)和拓展市場(chǎng)，滿足客戶的需求。
    帝康醫(yī)藥，歡迎您來(lái)電來(lái)函，期待與您合作！！